EUVIMEDEUVIMED entdecken
Scoping Review

Peripheral Artery Disease Treatment: Scoping Review with ☸️SAIMSARA

SAIMSARA Journal · 11.04.2026 · 1 (1)

DOI: 10.62487/saimsarafa4dc087 ↗

Kurz gefasst

Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 11.04.2026. Die Arbeit nennt 349 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this paper is to synthesize current evidence regarding the risk factors, diagnostic screening tools, and therapeutic interventions for peripheral artery disease, with a focus on improving limb salvage and cardiovascular outcomes. The review utilises 3585 original studies with 35864537 total participants (topic deduplicated ΣN). The mapped evidence suggests that contemporary peripheral artery disease care is most consistently strengthened by intensive secondary prevention, structured exercise, and selective revascularization, with dual-pathway inhibition standing out as a prominent signal: low-dose rivaroxaban plus aspirin was associated with a 43% reduction in major adverse limb events and a 58% reduction in total vascular amputations in stable peripheral artery disease, while post-revascularization analyses showed hazard ratios of about 0.85 to 0.86 for ischemic event reduction. Across the broader treatment landscape, supervised and home-based exercise improved walking performance, cilostazol and statins supported symptom and event reduction, and drug-coated balloons, drug-eluting stents, intravascular lithotripsy, and intravascular ultrasound-guided intervention were repeatedly associated with better procedural or patency-related outcomes in selected anatomic settings. At the same time, the evidence map highlights that treatment benefit is strongly modified by diabetes mellitus, chronic kidney disease, frailty, bleeding risk, and major socioeconomic and sex-based disparities in access to guideline-directed care. Clinically, these findings support a multidisciplinary model in which aggressive medical therapy, exercise rehabilitation, and anatomy-specific revascularization are integrated rather than treated as competing strategies. Because much of the literature remains heterogeneous and a substantial share is observational, future research should prioritize pragmatic and phenotype-specific trials that clarify optimal antithrombotic selection, limb-specific effects of newer metabolic therapies, and implementation strategies that reduce undertreatment and inequity in peripheral artery disease care.

Zitieren

APA

(2026). Peripheral Artery Disease Treatment: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(1). https://doi.org/10.62487/saimsarafa4dc087

Vancouver

Peripheral Artery Disease Treatment: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(1). doi:10.62487/saimsarafa4dc087

BibTeX
@article{euvimed2026,
  title = {Peripheral Artery Disease Treatment: Scoping Review with ☸️SAIMSARA},
  journal = {SAIMSARA Journal},
  year = {2026},
  volume = {1},
  number = {1},
  doi = {10.62487/saimsarafa4dc087}
}
Kostenlos starten →